Eyes on Soleno’s Prader-Willi syndrome drug launch

Adam Feuerstein is a senior author and biotech columnist, reporting on the crossroads of drug improvement, enterprise, Wall Road, and biotechnology. He’s additionally a co-host of the weekly biotech podcast The Readout Loud and writer of the publication Adam’s Biotech Scorecard. You’ll be able to attain Adam on Sign at stataf.54.

That is the web model of Adam’s Biotech Scorecard, a subscriber-only publication. STAT+ subscribers can join right here to get it delivered to their inbox.

Editor’s notice: The lead merchandise on Soleno Therapeutics was up to date with new data.

It feels very very similar to a mid-summer week. This article is taking a one-week hiatus, so search for the subsequent version on July 24.

STAT+ Unique Story

Have already got an account? Log in

This text is unique to STAT+ subscribers

Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.

Have already got an account? Log in

Particular person plans

Group plans

View All Plans